Molecular BiologyFrontiers in PharmacologyPeer-reviewed
Development of a Novel Bruton's Tyrosine Kinase Inhibitor that exerts Anti-Cancer Activities Potentiates Response of Chemotherapeutic Agents In Multiple Myeloma Stem Cell-Like Cells
Weam Othman Elbezanti, Omar S. Al‐Odat, Robert J. Chitren…·Manoj Kumar Pandey
This paper develops a novel BTK inhibitor, KS151, which effectively targets MM stem cell-like cells and enhances the response to chemotherapeutic agents.
9 citations